<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>17</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Involvement of CELSR3 Hypermethylation in Primary Oral Squamous Cell Carcinoma</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>219</FirstPage>
			<LastPage>223</LastPage>
			<ELocationID EIdType="pii">31830</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;b&gt;Background:&lt;/b&gt; Promoter hypermethylation is a frequent epigenetic mechanism for gene transcription repression in cancer and is one of the hallmarks of the disease. Cadherin EGF LAG seven pass G-type receptor 3 (CELSR3) contributes to cell contact-mediated communication. Dysregulation of promoter  methylation has been reported in various cancers. &lt;br/&gt;&lt;b&gt;Objectives&lt;/b&gt;: The objectives of this study were to investigate the CELSR3 hypermethylation level in oral squamous cell carcinomas (OSCCs) using methylation-sensitive high-resolution melting analysis (MS-HRM) and to correlate CELSR3 methylation with patient demographic and clinicopathological parameters. Materials and &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: Frozen tissue samples of healthy subjects’ normal mucosa and OSCCs were examined with regard to their methylation levels of the CELSR3 gene using MS-HRM. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: MS-HRM analysis revealed a high methylation level of CELSR3 in 86% of OSCC cases. Significant correlations were found between CELSR3 quantitative methylation levels with patient ethnicity (P=0.005), age (P=0.024) and pathological stages (P=0.004). A moderate positive correlation between CELSR3 and patient age was also evident (R=0.444, P=0.001). &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: CELSR3 promoter hypermethylation may be an important mechanism involved in oral carcinogenesis. It may thus be used as a biomarker in OSCC prognostication.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">CELSR3</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">hypermethylation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">oral squamous cell carcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Biomarker</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_31830_4fb553b8e3c350e98af90cff77e62cb0.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
